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ABSTRACT
One of the core activities of high-throughput pro-
teomics is the identification of peptides from mass
spectra. Some peptides can be identified using
spectral matching programs like Sequest or Mascot,
but many spectra do not produce high quality data-
base matches. De novo peptide sequencing is an
approach to determine partial peptide sequences
for some of the unidentified spectra. A drawback of
de novo peptide sequencing is that it produces a
series of ordered and disordered sequence tags and
mass tags rather than a complete, non-degenerate
peptide amino acid sequence. This incomplete data
is difficult to use in conventional search programs
such as BLAST or FASTA. DeNovoID is a program
thathasbeenspecificallydesignedtousedegenerate
amino acid sequence and mass data derived from
MS experiments to search a peptide database. Since
the algorithm employed depends on the amino acid
composition of the peptide and not its sequence,
DeNovoID does not have to consider all possible
sequences, but rather a smaller number of composi-
tions consistent with a spectrum. DeNovoID also
uses a geometric indexing scheme that reduces the
numberofcalculationsrequiredtodeterminethebest
peptide match in the database. DeNovoID is available
at http://proteomics.mcw.edu/denovoid.
INTRODUCTION
Recenteventsinanalyticalchemistryandgenomicshavecome
together to make high-throughput proteomics a possibility (1).
Many of the high-throughput proteomics efforts have adopted
the so-called ‘bottom up’ or ‘shotgun’ approach (2,3). In the
bottom up approach, the biological sample to be analyzed is
converted from a complex mixture of proteins into an even
morecomplex mixtureof peptidesby digestionwith aprotease
of deﬁned speciﬁcity, such as trypsin. Typically this mixture
is then separated with liquid chromatography and introduced
into a mass spectrometer by electrospray. The development
of improved nanospray ionization methods allows for a high-
resolution mass spectrometer to be used in-line with multi-
dimensional liquid chromatography (2,4–6). This LC–MS/MS
setup allows for the high-throughput analysis of complex mix-
tures of peptides produced from biological samples such as
body ﬂuids including blood and cerebral spinal ﬂuid, or from
extracts of cells or tissues.
Asthe genomicdata formany species approachescomplete-
ness, the list of known and possible proteins produced by those
species also approaches completeness (7–9).With these nearly
complete proteomes in hand, it is now possible to search for
matches between mass spectra and the particular proteome
database with some degree of conﬁdence that a form of the
protein producing the observed peptide will be present in the
database.
One of the major impediments to high-throughput pro-
teomics continues to be problems associated with peptide
identiﬁcation from mass spectral data (10–12). The standard
methods for comparing a spectrum to the proteome database
involve the matching of the experimental spectra to theoretical
spectra calculated from all of the predicted peptides. Studies
measuring the accuracy of the peptide identiﬁcations under
near ideal conditions ﬁnd that only 7–10% of the identiﬁca-
tions are correct (13). There are a number of reasons for this
low success rate. First, many of the spectra may not be authen-
tic peptide spectra or may be spectra of two or more co-eluting
peptides. Second, the peptide may contain post-translational
modiﬁcations or experimentally induced changes that were not
accounted for by the search algorithm. Third, the peptide may
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An approach that addresses the last two problems is de novo
peptide sequencing which is an attempt to determine the
complete or partial sequence of the peptide from the experi-
mental spectra (14–19). De novo peptide sequencing tries to
determine the mass difference between sequential b and
sequential y ions in the MS/MS spectra. The mass differences
can then be matched to amino acid masses and a potential
sequence deduced. Several different methods using this
approach have been developed (14,16,18,20–28). Often, the
de novo peptide sequencing program only produces a limited
number of ordered sequence tags; regions for which the amino
acid composition and sequence is known. In addition, de novo
peptide sequencing can also produce unordered sequence tags;
regions for which the amino acid composition is known, but
the order of the amino acids cannot be determined. Lastly,
since the smallest and largest b and y ions are often not
observed in the spectra or in regions that ionize poorly, the
de novo peptide-sequencing program is unable to assign any
sequence to that portion of the peptide and instead reports a
mass tag. These mass tags often can correspond to multiple,
completely independent amino acid compositions. Thus, the
typical result from de novo peptide sequencing is a collection
of ordered sequence tags, unordered sequence tags and mass
tags that are consistent with large number of potential peptide
sequences.
Although de novo peptide sequencing is more robust with
respect to peptide modiﬁcations or changes than the spectral
matchingapproach,thedegenerateresultsproducedbydenovo
peptide sequencing do not answer the fundamental question:
which proteins are present in the original sample. To do this,
the results obtained from de novo peptide sequencing must be
used in a database search. The matching algorithms used by
the common search programs, BLAST (29) and FASTA
(30,31), are suboptimal with small sequence queries such as
the typical peptides observed in these experiments, 8–25
amino acids. Versions of these programs to deal better with
these smaller queries have been produced (24,25,32,33), but
fundamentally, the problem of incomplete knowledge of the
sequence still exists. Additionally, all of the possible peptides
consistent with the set of degenerate unordered sequence and
mass tags need to be calculated and then submitted to the
search program. This greatly increases the search time and
also raises the expectation that a false positive identiﬁcation
will result.
We have developed a method for indexing and searching a
peptide database that is not dependent on the amino acid
sequence of the peptide, only its amino acid composition
(34). This method works optimally with peptides in the size
range observed in the high-throughput proteomics experi-
ments described above. Since this method uses a hierarchical
index instead of pairwise comparisons, it requires far fewer
computational steps to identify the best match in a peptide
database. By marrying this database search algorithm with a
web-based front end that accepts the degenerate de novo pep-
tide sequencing results, we have produced the DeNovoID web
service. DeNovoID is capable of expanding the de novo pep-
tide sequencing results, searching a pre-indexed peptide data-
base and determining the closest peptide match in the database
to the de novo sequencing results.
MATERIALS AND METHODS
Algorithms
The results from a de novo peptide sequencing experiment are
used to determine the potential amino acid compositions that
then become a query to the PepID indexed peptide database.
The ordered and unordered sequence tags are combined and
composition information is extracted. The mass tags are com-
pared to a list of potential peptide masses to identify all pos-
sible combinations of up to three amino acids that match the
mass tag within the given experimental error. A list of all
possible mass tag compositions are combined with the com-
position deduced from the sequence tags to produce a com-
prehensive list of possible amino acid combinations that are
consistent with the de novo peptide sequencing experimental
results. This list of potential peptide compositions is then
submitted to the PepID database search algorithm.
The PepID algorithm for constructing and searching peptide
databases has been previously described by Halligan et al.
(34) and is outlined in Figure 1A. Brieﬂy, a ﬁle of protein
sequences in fasta format is parsed and the sequences digested
in silico using the trypsin cleavage speciﬁcity to produce a list
of potential peptides. The peptides, smaller than those that
wouldbeexpectedtobeexperimentallyobserved,areremoved,
since they do not contain enough information to be uniquely
mapped to a single protein in the database. This has the beneﬁt
of speeding the ensuing calculations. The peptides are then
converted into 18 dimensional vectors based on their amino
acid composition. Eighteen dimensions are used instead of
twentydimensionsbecausetwopairsofaminoacids,glutamine
and lysine or leucine and isoleucine, are difﬁcult or impossible
to distinguish based on mass, so this pair of amino acids is
represented by one dimension. The vectors are then clustered
basedonEuclideandistanceintolargetop-levelclusters,which
are then further sub-clustered into smaller clusters, each of
whichhaveanassociatedlistofpeptides(Figure1A).Tosearch
the database, the compositions deduced from the de novo
peptide sequencing results are converted to vectors as above
and the hierarchy of the database is traversed by determining
the cluster centers at each level with the shortest Euclidean
distance to the experimental vector (Figure 1B).
RESULTS AND DISCUSSION
Purpose
One of the major drawbacks of de novo peptide sequencing is
that the degenerate results that it often produces do not directly
answer the fundamental question that the investigator wants
to answer: what proteins are present in the biological sample
being analyzed? To answer this question, the results of the
de novo peptide sequencing must be used to query a protein or
peptide database. When using the normal tools for protein
database searching, BLASTandFASTA,twodifﬁculties arise.
One problem is that the short length of the query sequences
do not perform well with the BLAST or FASTA search algo-
rithms. The FASTA search algorithm has been improved to
better utilize short peptides as a query (33). It does not how-
everacceptmasstagsandunorderedsequencetags.Thesemust
ﬁrst be converted to all possible combinations of sequences
and then submitted.
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methods in that it allows the results obtained from de novo
peptide sequencing to be searched against an indexed peptide
database.
Audience
The intended audience for the DeNovoID web service is
proteomics researchers using de novo peptide sequencing to
identify peptides by mass spectrometry. It has been found that
many spectra that appear to be authentic peptide spectra do not
lead to conﬁdent identiﬁcations using the standard database
search methods. A number of commercial and open source
programs are now available to perform de novo peptide
sequencing with these spectra (20,22,24,32,35,36) (DeNovoX,
Thermo-Finnigan). The DeNovoID web service complements
these efforts by providing a means to take the output of the
de novo peptide sequencing programs and carry out an
optimized database search in a single step.
Technical description
Scoring. The algorithm used by DeNovoID is based on map-
pingthe compositionof each peptide toavector,allowing pep-
tidestobecomparedusingvectoralgebra.Eighteendimensions
are used instead of twenty because pairs of amino acids that
are difﬁcult to distinguish by mass spectrometry (isoleucine
and leucine, and lysine and glutamine) are combined. The
peptide composition is mapped to each of the elements of the
vector using the following formula: hi ¼ aln ni þ 1 ðÞ   b‚
i ¼ 1‚:::‚18, where hi is the standardized value and ni is
the fractional composition of the amino acid in the peptide.
The standardization parameters a and b were chosen to be
a=6, b=3 to provide an appropriate set of vector lengths for
use by the clustering algorithm. The Euclidean distance
between two vectors is a measure of dissimilarity between
the peptides and is used as the score. A score of 0 indicates
compositional identity and a score of <1 indicates a high
degree of compositional similarity.
Mass tags. Mass tags are converted to amino acid composi-
tions by including all possible combinations of up to four
amino acids that match the mass tag within the speciﬁed
mass tolerance. The default tolerance for the accuracy of the
mass determination is 1 Da and the mass tolerance can be
altered by the user using the web interface. Additionally,
the user can have the mass of the tag automatically adjusted
for ion type. Since a b ion carries an additional N-terminal H,
the mass of the tag should be reduced by 1 Da before search-
ing. DeNovoID automates this process. If the user includes
a # symbol at the end of the mass tag, DeNovoID will auto-
matically subtract 1 Da from the b ion mass tag before
generating the matching amino acid combinations. Similarly,
a yioncarries an N-terminalHandaC-terminalOH.Including
‘@’ symbol at the end of the mass tag causes DeNovoID to
automatically subtract 19 Da from the mass tag.
Overview
Input.The input to the DeNovoID web service can take several
differentformats.Thesimplestuseistopasteaquery sequence
in the sequence entry box on the form. The query is in the
fasta format sequence composed of a header line beginning
with the ‘>’ character followed by an optional description of
the query, followed by one or more lines containing the query.
The query can consist of a mixture of ordered sequence tags,
disordered sequence tags (sequence contained within square
brackets) and mass tags (numeric values contained within
square brackets). DeNovoID takes all three types of informa-
tion and creates a set of possible peptide compositions for the
search (Figure 2).
Multiple sequences can be submitted in batch by inputting
multiple queries in the sequence entry box on the form. Each
query begins with a fasta header line. A text ﬁle containing
multiple queries in the same format can also be uploaded by
selecting the ﬁle using the browse function of the form. Enter-
ing a ﬁlename foruploadtakes precedence over data entered in
the sequence entry box on the form.
While many searches with simple single queries can be
completed rapidly, complex searches with multiple mass tags
Figure1.OverviewofPepID/DeNovoIDalgorithms.(A)Flowchartdescribing
creation of the indexed peptide database. (B) Flowchart describing the method
for matching a query peptide to the closest database entry.
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complete than the time-out limit ( 1 min) of some web brow-
sers. For this reason, the results of the DeNovoID search are
returned by email as an attached hypertext markup language
(html) document. A box on the form is provided to enter the
email address to which the results should be returned.
The PepID algorithm determines the quality of match
between a query and a database peptide by measuring the
Euclidean distance between the vectors representing the
query and database peptides. The cutoff score box provides
the user an opportunity to examine matches that are close, as
well as those that are exact. If zero or no value is entered in the
cutoff score box, only exact matches are reported. A cutoff
value of <2.5 is usually sufﬁcient to detect all biologically
relevant matches and allows for the identiﬁcation of peptides
with one or two amino acid substitutions. Amino acid substi-
tution is an important reason for failure of spectral correlation
based database search algorithms.
Output. The output of the DeNovoID search is an html ﬁle that
isreturnedtothe user by email asan attachedﬁle. The htmlﬁle
has three sections: a header, a description of the database used
for the search and the results of the search.
The header contains information about which database was
selected, the type of the database, the cutoff value to be used
for reporting the results of the search, the email address to
which the results are to be returned, and the time and date of
the search. The database description section contains the name
of the fasta ﬁle used to produce the database, the enzyme
cleavage used and the number of missed cleavages allowed,
the minimum and maximum peptide sizes for inclusion in the
databases, the number of proteins and peptides included in
the database, the options used in generating the database and
the program version used to generate the database, and date on
which it was generated (Figure 3).
The results section of the html ﬁle is organized into blocks
corresponding to each query. The header and query are
Figure 2. DeNovoID User Interface showing a query containing a mass tag.
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tions generated corresponding to the query. A table of exact
matches is reported showing the number of ordered sequence
tags that were matched in the query, the peptide composition
used for the search, the name of the protein matched and the
peptide sequence that matched with the ﬂanking amino acids
indicated. The protein name is also a link to the database entry
for that protein. Ordered sequence tags that are found in the
matched peptide are indicated by the use of bold red text. If a
non-zero value is supplied for the cutoff value, a table of close
matches, with a score less than or equal to the cutoff value is
also reported.
CONCLUSIONS AND FUTURE DIRECTIONS
As high-throughput proteomics matures as a ﬁeld, it is clear
that amino acid variation and modiﬁcation are important fac-
tors in the analysis of proteomic data. By their inherent nature,
database search algorithms that rely on spectral matching are
limited by these types of differences between the database and
actual peptides. To overcome these limitations, de novo pep-
tide sequencing algorithms can be used to determine sequence
tags directly from the spectral information. This approach is
also limited in that incomplete sequence determination often
leads to results containing disordered sequence and mass tags.
These degenerate elements make using these results in stand-
ard sequence search algorithms difﬁcult. Another webservice,
Spider (http://bif.csd.uwo.ca/spider), which also searches pro-
tein databases with a query composed of sequence and mass
tags has been recently released, further demonstrating the need
for this type of analysis.
DeNovoID provides a method for searching a peptide
database using amino acid composition and is optimized for
peptides of the typical length observed in high-throughput
proteomics experiments. By using composition instead of
sequence, as well as an algorithm that is peptide length
independent, many of the problems associated with standard
sequence search methods are avoided. Currently, DeNovoID
takes text queries in fasta format. In the future, we would like
to extend DeNovoID to accept output ﬁles from the major
Figure 3. DeNovoID Results Output A peptide from bovine serum albumin (YLYEIAR) is used to demonstrate DeNovoID’s ability to use mass tags as input. The
firsttwoaminoacids(YL)arereplacedwiththeirapproximatemolecularweight(276Da)andthequeryissubmittedtotheDeNovoID.Resultsarereturnedbyemail
as an html file attachment. Links to sequence databases are shown in blue and matched tags are shown in red.
W380 Nucleic Acids Research, 2005, Vol. 33, Web Server issuede novo peptide sequencing programs and to provide a facility
so that other programs can easily submit queries to DeNovoID
as a link in their results.
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